THE WORLD HAS A COVID19 CURE
I took this screenshot above today, May 18, 2020. India's population as of today is 1.3 BILLION people. They only have 3,163 Covid-19 related deaths. Pretty impressive numbers knowing they are using Hydroxychloroquine to treat patients infected with Covid-19 nationwide. Worldmeters reports that India population is equivalent to 17.7% of the total world population. Wow. (emphasis mine)
India advised all front line health care workers to take Hydroxychloroquine prophylactically. This was in March. pic.twitter.com/cEFOc88WY6— Adosologist (@Billtheicon) May 18, 2020
The Hindu
written by Staff
Sunday May 17, 2020
India on Sunday extended the coronavirus lockdown for two more weeks with the fourth phase providing more relaxations outside the containment zones including inter-state movement of buses with mutual consent of states that is expected to be of immediate relief for thousands of migrant workers on the roads.
Easing more curbs to step up economic activity, the new guidelines for lockdown 4.0 unveiled by the Ministry of Home Affairs (MHA) till May 31 allowed shops and markets including barber shops, salons and spas except those in malls to open with staggered timings. E-commerce companies were also permitted to deliver all goods, including those considered non-essential.
However, the night curfew will remain which meant that all non-essential travel will remain prohibited between 7 pm and 7 am and authorities will ensure strict compliance, the MHA said.
As the country recorded the highest single day spike of 4,987 new cases, the states were allowed to demarcate the red, green and orange zones depending upon COVID-19 case load, a demand made by chief ministers of several states and union territories. The MHA said the same should be done after taking into consideration of parameters outlined by the Ministry of Health and Family Welfare.
Early hydroxychloroquine Morocco is still facing a growing number of COVID cases, but barely any growth in the number of fatalities.— Covid19Crusher (@Covid19Crusher) May 17, 2020
India has just accepted their order for a 6 million pills refill.https://t.co/enE0YFakLP pic.twitter.com/jdEQgiBg0O
Nikkei Asian Review
written by Rosemary Marandi and Raj Kumar Sharma, Contributing writers
Monday May 18, 2020
MUMBAI/NEW DELHI -- India is spending around $16 million -- half of it in Africa -- on pharmaceuticals, test kits and other medical assistance for some 90 countries battling the COVID-19 pandemic.
The South Asian nation has already sent consignments of hydroxychloroquine (HCQ), paracetamol and other drugs to 25 African countries at a total cost including transportation of around 600 million rupees ($7.9 million), according to a foreign ministry source.
"We worked out a list of essential drugs keeping their requests in mind," the official told the Nikkei Asia Review on condition of anonymity. "Transportation is a problem, but we are trying to reach them by the end of May or early June."
"HCQ has a preventive use, although there is no conclusive evidence on its efficacy against coronavirus," a medical officer posted in one of the COVID-19 hospitals in New Delhi told Nikkei.
According to the Indian Council of Medical Research, the anti-malarial HCQ can be used as a prophylaxis to prevent COVID-19 infection, but not as a treatment. It can be taken by doctors, health care workers and close contacts of COVID-19 cases. U.S President Donald Trump once promoted the drug as a coronavirus "game changer," but lately he has toned it down.
"Paracetamol is used in symptomatic care in COVID-19 cases where we see fever," the medical officer said. He noted that most of the HCQ supplied by India to Africa is going to sub-Saharan countries threatened by malaria. The World Health Organization has warned that malaria deaths could double in that region in 2020 because of disruptionns caused by the pandemic.
Assistance to Africa and Latin America is the second phase of India's COVID-19 health diplomacy initiative, and follows assistance to immediate South Asian neighbors. On Mar. 15, Prime Minister Narendra Modi committed $10 million from an emergency fund to assisting seven fellow members of the South Asian Association for Regional Cooperation.
India has also sent medical supplies, including masks and other types of personal protective equipment to countries around the Indian Ocean and in Central Asia, and also to six African nations.
The official at the Ministry of External Affairs told Nikkei that it has committed to medical aid worth 600 million rupees for 67 countries. Procurement orders have already been placed with government agencies and state-owned companies, such as Kerala-based HLL Lifecare. The ministry is also providing financial aid to some countries and regional funds.
India is donating 10 million hydroxychloroquine tablets to the 67 countries, with nearly 30% already delivered to 24 of these. Requests for medical assistance from 35 countries, mostly in Africa and West Asia, are being processed.
The country's defense forces have been enlisted to help in the health diplomacy, particularly in the Indian Ocean. In early April, the Indian air force delivered 6.2 tonnes of essential medicines to the Maldives using a C-130 Hercules transport aircraft. On May 10, the Indian naval vessel INS Kesari set out for the Maldives, Mauritius, the Seychelles, Madagascar and the Comoros, with food items and medicines, including traditional Indian remedies.
India is also trying to help with capacity building by offering health care training for COVID-19 management and protocols to 160 countries. It has also offered training in lockdown management to some foreign police forces. The foreign ministry official said concept papers have been invited for upgrading hospitals and vaccine centers.
India has previously helped countries like Sri Lanka and the Maldives build hospitals and health care centers. "This is an opportunity for India to prove itself not only as the pharmacy to the world but also a net public health security provider," an diplomat told Nikkei.
With a population of around 1.3 billion, India is facing a major battle of its own fighting COVID-19, but officials believe it can still play a global role. "Our pharma companies have the capacity to not only take care of India's needs but of other countries as well," said Harsh Pant, a professor of international relations at King's College in London.
India's diplomatic play comes at a crucial juncture in international politics as the U.S. and China argue over the precise origin of the novel coronavirus amid widespread concerns over their respective shortcomings in the crisis.
"Through its health diplomacy, India may be trying to carve out an independent space for itself," Pant told Nikkei. "The world looks set for a new Cold War between the U.S. and China -- COVID-19 may have brought the middle power moment in international politics."
"The post-coronavirus world order could create space for a group of middle powers to provide global leadership," said Gautam Bambawale, a former Indian ambassador to China. He believes Japan, India, France and South Africa are among the countries that could become more influential.
The esteemed Professor Paolo Zanotto, Professor of Microbiology at the University of Sao Paulo, has released a list of 50 scientific references supporting the use of hydroxychloroquine for COVID-19.https://t.co/vSpsmWOxto pic.twitter.com/KqA96KesVh— Jean-Pierre K. (@jpkiekens) May 17, 2020
A state in Nigeria has adopted the Zelenko protocol— Hydroxychloroquine News (@niro60487270) May 18, 2020
"Jigawa State has unveiled the secret behind the quick recovery of its COVID-19 patients... patients were treated through the use of Hydroxychloroquine, azithromycin, zinc and vitamins."
HT @jtyoung18 https://t.co/j8QylXUcD6
Thank you President @JuanOrlandoH and @drleosan and Dr. Lysien Zambrano. I am grateful for the opportunity to advise and assist you and your team, in your tireless efforts to safeguard and preserve the lives of the people of the Republic of Honduras.— Dr Vladimir (Zev) Zelenko (@zev_dr) May 2, 2020
Russia is using hydroxychloroquine, it also reports significantly fewer deaths from Covid-19 compared to other countries similarly hit by the pandemic. So, the New York Times claimed Russia was under reporting deaths. Russia is now demanding a retraction.https://t.co/Tv33brdRhs— Hydroxychloroquine News (@niro60487270) May 18, 2020
The Covid-19 fatality rate remains at 1% in Senegal as the country continues to broadly use hydroxychloroquine "despite warnings from the World Health Organization."https://t.co/ShsUDtgAZl pic.twitter.com/7ncWvI25Ne— Hydroxychloroquine News (@niro60487270) May 17, 2020
Turkey, a country that has fully embraced hydroxychloroquine for covid-19, reported its lowest daily death toll since March. Its case fatality rate currently stands at less than half of the United States'.https://t.co/WtqRjr6NGS— Hydroxychloroquine News (@niro60487270) May 17, 2020
Malaysia has used hydroxychloroquine since the first wave of the Covid-19 outbreak. The recovery rate there now exceeds 80%. The country of over 30 million people only has 1,247 active cases.https://t.co/ni9wm9CZBP— Hydroxychloroquine News (@niro60487270) May 16, 2020
For chloroquine and hydroxychloroquine, when used at normal malaria treatment doses (and duration), prior 2017 WHO publications report that there has never been a case of cardiac arrhythmia reported. https://t.co/DuA2RN8qBc Data to date on QT prolongation:— David Boulware, MD MPH (@boulware_dr) April 28, 2020
NIH begins randomized clinical trial in 2000 patients assessing hydroxychloroquine + azithromycin in treatment of EARLY stage COVID-19.— James Todaro, MD (@JamesTodaroMD) May 15, 2020
It’s strange that the NIH would do this when the revered medical journal Washington Post told us HCQ kills people.https://t.co/mNzM0cAXY0
And here’s the kicker. The NIH even admits the HCQ+AZ treatment combination is likely safe for use in pregnant and breastfeeding women with #COVID. pic.twitter.com/6wEW6AN8kQ— James Todaro, MD (@JamesTodaroMD) May 15, 2020
I've been asked by physicians to compile and summarize the evidence on hydroxychloroquine and azithromycin in treatment of #COVID19, as well as info on safety/side effects.— James Todaro, MD (@JamesTodaroMD) April 6, 2020
I intend to update this document ~daily as new evidence surfaces. #coronavirushttps://t.co/KlyVOGExV1
Dr. Ivette Lozano: "The People of the United States Need to Know They Have a Brilliant President"— Chris R. (@Coffee_2222) May 19, 2020
James Hofthttps://t.co/ltpOBlWlGp
SKIN IN THE GAME: President Trump joins many front-line healthcare workers by announcing that he has been taking HYDROXYCHLOROQUINE + ZINC for the past couple of weeks for #COVID19 prophylaxis.https://t.co/0hpQbcSL1q— James Todaro, MD (@JamesTodaroMD) May 18, 2020
"He’s our president, and I would rather he not be taking something that has not been approved by the scientists, especially in his age group and in his, shall we say, weight group.— Washington Examiner (@dcexaminer) May 19, 2020
Morbidly obese, they say. So, I think it’s not a good idea." – @SpeakerPelosi pic.twitter.com/anwujuPHux
To the left, it's ok if Nancy Pelosi calls Trump #morbidlyobese... but could you imagine the complete meltdown if Trump called... just spitballing here... Stacey Abrams #morbidlyobese.— Tim Young (@TimRunsHisMouth) May 19, 2020
President insults anyone: BENEATH THE DIGNITY OF THE OFFICE!— Razor (@hale_razor) May 19, 2020
Speaker of House insults President: LIKE A BOSS, AND NATIONAL TREASURE!
— Hydroxychloroquine News (@niro60487270) April 9, 202090-year-old woman survives Covid-19 after treatment with hydroxychloroquine.https://t.co/qdEOz8R7cq
95-year-old #GertrudeFatton refused to be intubated to help her breathing.— Armond Ray Erickson (@ArmonRaE) March 29, 2020
After a week of #COVID19 treatment with antibiotics & the malaria medicine #chloroquine, she said she was now happy to be back home with her cat and her family.https://t.co/cmwWHExVI0#VentilatorShortage
Every article I am reading today is HATING on #Hydroxychloroquine - an FDA APPROVED drug.— Bill Mitchell (@mitchellvii) April 14, 2020
P.S., The FDA also approved this for use to treat COVID-19.
But the #Media claims it is just "an anti-malaria drug Trump 'touts' as a cure."
The #Media literally wants people to die.
BREAKING: The United States FDA has issued an emergency authorization of anti-malaria drug Hydroxychloroquine to be prescribed to COVID-19 patients.— Mike Coudrey (@MichaelCoudrey) March 30, 2020
Previously the drugs prescription to treat COVID-19 was considered “off-label” use. pic.twitter.com/3KEE6xmIgH
UPDATE 5/19/20 at 12:25am: Added info below.#Hydroxycloroquine was APPROVED for medical use in 1955 - Over 65 Years Ago! Is in the W.H.O. list of “Essential Medicines, the Safest & MOST EFFECTIVE medicines in the health system”. In 2017, #Hydroxychloroquine was 128th MOST COMMONLY PRESCRIBED MEDICATION in the UNITED STATES pic.twitter.com/ty7y9TPJrL— Kenny (@Kennykwh1120) May 19, 2020
The Association of American Physicians and Surgeons (AAPS) presents a frequently updated table of studies that report results of treating COVID-19 with anti-malaria drugs chloroquine (CQ) and hydroxychloroquine, about 90 Percent Success Rate. [4/28/2020]https://t.co/I9gTSu8mUW— Global Awareness 101 (@Mononoke__Hime) May 19, 2020
The HCQ-AZ combination, when started immediately after diagnosis, appears to be a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagious infectivityhttps://t.co/B5bRZL5YRc— Global Awareness 101 (@Mononoke__Hime) May 19, 2020
UPDATE 5/19/20 at 12:52am: Added info below.Another interesting table by @gummibear737 looking at adjusted life-years lost due to flu/pneumonia vs COVID-19 from Feb 1 - May 13, 2020.— James Todaro, MD (@JamesTodaroMD) May 16, 2020
Of note, more life-years have been lost to the seasonal flu/pneumonia than COVID-19 over the same period in 2020. pic.twitter.com/Su9O9s7cSw
Coronavirus Victims Die While US State And Local Government Hoards hydroxychloroquine (HCQ) Medication— Global Awareness 101 (@Mononoke__Hime) May 19, 2020
...in nursing homes, victims of COVID-19 are still unable to access HCQ, states the Association of American Physicians & Surgeons (AAPS). [5/4/20]https://t.co/rqZCmnDIF9
No comments:
Post a Comment